Drugs / dLOS-TT
last change Apr 2001 re-read 3 minutes ago

dLOS-TT

also known as dLOS-TT vaccine

Vaccine

Developed for
otitis media
Investigated by
National Institute on Deafness and Other Communication Disorders (NIDCD)

Trials 1

1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00001605 May 1997 → Apr 2001 otitis media National Institute on Deafness and Other Communication Disorders (NIDCD) Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as dLOS-TT “Researchers would like to test the effectiveness and safety of dLOS-TT vaccine in adult humans.” NCT00001605 ↗
Known as dLOS-TT vaccine “Researchers would like to test the effectiveness and safety of dLOS-TT vaccine in adult humans.” NCT00001605 ↗
Modality Vaccine “This investigational vaccine also showed protection against infection in a chinchilla otitis media model.” NCT00001605 ↗